Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Biogen (BIIB) PT Lowered to $337 at RBC Capital
January 30, 2019 6:25 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $337.00 (from $342.00) while maintaining a Sector Perform rating.
... MoreBiogen (BIIB) PT Raised to $380 at Oppenheimer
January 29, 2019 5:29 PM ESTOppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $380.00 (from $372.00) while maintaining a Outperform rating.
Olson noted an 'impressive' Q4 performance which featured a business update that perplexed investors with plans for an intriguing Alzheimer's prevention study.
... More